Ishita Drugs and Industries Limited (BOM:524400)
India · Delayed Price · Currency is INR 73.75
-0.25 (-0.34%)
At close: Sep 11, 2026
BOM:524400 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 124.05 | 146.6 | 149.97 | 151.88 | 120.72 | 140.9 | |
Revenue Growth | -28.59% | -2.25% | -1.25% | 25.80% | -14.32% | 1.01% |
Cost of Revenue | 79.89 | 124.97 | 126.13 | 129.37 | 100.12 | 118.14 |
Gross Profit | 44.16 | 21.63 | 23.85 | 22.5 | 20.6 | 22.76 |
Selling, General & Admin | 14.18 | 13.97 | 13.83 | 13.42 | 12.98 | 11.85 |
Other Operating Expenses | 22.62 | -0.33 | 0 | - | - | - |
Operating Expenses | 38.01 | 14.63 | 14.93 | 14.53 | 14.28 | 13.15 |
Operating Income | 6.15 | 7 | 8.92 | 7.97 | 6.32 | 9.61 |
Interest Expense | -0.41 | -0.37 | -0.35 | -0.62 | -0.37 | -0.04 |
Interest & Investment Income | - | 4.4 | 3.36 | 2.8 | 2.01 | 1.06 |
Other Non Operating Income (Expenses) | 4.18 | -0.22 | -0.38 | -0.28 | -0.17 | -0.2 |
Pretax Income | 9.93 | 10.8 | 11.55 | 9.87 | 7.79 | 10.43 |
Income Tax Expense | 2.87 | 3.02 | 2.87 | 2.39 | 2.02 | 2.38 |
Net Income | 7.06 | 7.78 | 8.68 | 7.49 | 5.77 | 8.05 |
Net Income to Common | 7.06 | 7.78 | 8.68 | 7.49 | 5.77 | 8.05 |
Net Income Growth | -30.95% | -10.32% | 15.98% | 29.63% | -28.27% | -2.97% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 2.36 | 2.60 | 2.90 | 2.50 | 1.93 | 2.69 |
EPS (Diluted) | 2.36 | 2.60 | 2.90 | 2.50 | 1.93 | 2.69 |
EPS Growth | - | -10.35% | 16.00% | 29.53% | -28.25% | -2.89% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 20.68 | -38.21 | 20.94 | -30.32 | 30.58 |
Free Cash Flow Per Share | - | 6.92 | -12.78 | 7.00 | -10.14 | 10.23 |
Gross Margin | 35.60% | 14.75% | 15.90% | 14.82% | 17.07% | 16.16% |
Operating Margin | 4.96% | 4.77% | 5.95% | 5.25% | 5.24% | 6.82% |
Profit Margin | 5.69% | 5.31% | 5.79% | 4.93% | 4.78% | 5.71% |
Free Cash Flow Margin | - | 14.11% | -25.48% | 13.79% | -25.11% | 21.70% |
EBITDA | 7.12 | 7.99 | 10.01 | 9.08 | 7.62 | 10.91 |
EBITDA Margin | 5.74% | 5.45% | 6.68% | 5.98% | 6.31% | 7.74% |
D&A For EBITDA | 0.97 | 1 | 1.1 | 1.12 | 1.29 | 1.3 |
EBIT | 6.15 | 7 | 8.92 | 7.97 | 6.32 | 9.61 |
EBIT Margin | 4.96% | 4.77% | 5.95% | 5.25% | 5.24% | 6.82% |
Effective Tax Rate | 28.85% | 27.92% | 24.85% | 24.18% | 25.92% | 22.82% |
Revenue as Reported | 128.23 | 151.33 | 153.33 | 154.68 | 122.73 | 141.97 |
Advertising Expenses | - | 0.01 | 0.02 | 0.02 | 0.15 | 0.04 |